In 1977, Abbott Laboratories and the Japanese pharmaceuticals manufacturer Takeda formed a 50-50 joint venture, Takeda-Abbott Products, to engage in pharmaceutical research and development. In 1985 the parties converted it into a Delaware corporation, TAP Pharmaceuticals, which they continued to own equally; each of the joint venturers was therefore entitled to choose half the members of TAP’s board of directors. The 1985 agreement also expanded the scope of the joint venture to include the distribution of pharmaceuticals. In that regard the agreement provided that both Abbott and Take-da could contract with TAP to furnish it with bulk product for it to distribute. TAP was to select bulk suppliers “on the basis of the economic advantage to TAP,” but was to give the original supplier of the bulk product “the first opportunity to quote on” resupplying it. The parties further agreed “to utilize their voting power in [TAP] in such a manner as to effectuate the intent of’ both the 1977 and 1985 agreements.
In 1995 Takeda made a contract to supply TAP for ten years with bulk lansopra-zole, a drug for treating symptoms of heartburn and acid reflux, which TAP marketed under the name Prevacid. In 2004, shortly before the contract expired, TAP’s board of directors voted to renew it. Six months later Abbott filed this suit against Takeda. The complaint charges that the defendant, in breach of a fiduciary duty to Abbott imposed by Delaware law (remember that TAP is a Delaware corporation), had coerced Abbott to instruct its directors on TAP’s board to vote to renew the contract, even though the contract price was excessive. Takeda had been able to coerce Abbott, the complaint explains, by threatening to stop supplying lansoprazole to TAP. How such a threat could be credible is unclear; and one might also wonder how Takeda could benefit from forcing TAP, of which it was half owner, to pay an exorbitant price for a critical input. Wouldn’t that be cutting off one’s nose to spite one’s face? Abbott’s answer is that by forcing renewal at an exorbitant price and thus increasing Take-da’s profits but TAP’s costs (and so reducing TAP’s profits), Takeda would come out ahead because half of TAP’s profits go to Abbott but all of Takeda’s profits go to Takeda.
Abbott filed its suit in the federal district court in Chicago, basing federal jurisdiction on diversity of citizenship. The choice of forum was a surprise. The 1985 agreement between Abbott and Takeda that created TAP states that “in the event of a dispute between [Abbott and Takeda] arising from, concerning or in any way related to this Agreement,” suit shall be brought in Japan if Abbott is the plaintiff and in Illinois if Takeda is the plaintiff. The purpose of specifying two forums in this way is to discourage either side from instituting litigation, because whoever sues must litigate on the other party’s turf. Compare
Carnival Cruise Lines, Inc. v. Shute,
The 1985 agreement states that it “shall be governed by the laws of the State of Illinois.” But there is a question whether this provision bound the district court, and binds us, with respect to forum selection. We left open the question whether federal or state law governs the validity and interpretation of such clauses in diversity suits in
IFC Credit Corp. v. Aliano Brothers General Contractors, Inc.,
Simplicity argues for determining the validity and meaning of a forum selection clause, in a case in which interests other than those of the parties will not be significantly affected by the choice of which law is to control, by reference to the law of the jurisdiction whose law governs the rest of the contract in which the clause appears,
Northwestern National Ins. Co. v. Donovan,
But while as we noted in
IFC Credit Corp. v. Aliano Brothers General Contractors, Inc., supra,
The clause is about as broadly worded as could be imagined, and at least as a semantic matter it certainly embraces Abbott’s suit. The breach of fiduciary obligation of its co-venturer about which Abbott complains arose out of the corporate structure created by the agreement, out of the provision of the agreement relating to contracts with bulk suppliers, out of the deadlock potential that the contractual provision for a 50-50 division of shares and directors created, and out of the contractual duty of the parties to vote their shares in a manner that would achieve the purpose of the agreement, which was to share profits equally — an intent that Takeda’s conduct, if Abbott can be believed, flouted. So the wrong of which Abbott’s suit complains arises from the 1985 agreement and even more clearly is related to it — the first thing a court asked to adjudicate the suit would want to look at would be the agreement.
Abbott argues, however, that under Illinois principles for the interpretation of forum selection clauses, a dispute “relates to” an agreement only if resolution of the dispute requires interpretation of the agreement. This would mean that if Take-da acknowledged breaking the contract, Abbott wouldn’t have to sue in Japan because there would be no interpretive issue. That makes no sense; and the case that Abbott cites in support,
Boatwright v. Delott,
Abbott repeats its argument in different words when it says that since its suit is a tort suit — a suit for breach of a fiduciary duty to a partner in a joint venture — it arises out of Delaware tort law rather than out of the 1985 agreement. But the forum selection clause does not apply just to the litigation of
claims
that arise out of, concern, etc., the contract; it applies to the litigation of
disputes
that arise out of, concern, etc., the contract.
American Patriot Ins. Agency, Inc. v. Mutual Risk Management, Ltd.,
Abbott cites
Parfi Holding AB v. Mirror Image Internet, Inc.,
Illinois conflicts of law principles do suggest that Delaware law governs Abbott’s claim of breach of fiduciary duty.
Spillyards v. Abboud,
It was natural for parties in the position Abbott and Takeda were in when they negotiated the 1985 agreement to want a dispute arising from an alleged abuse of voting power to be encompassed by the forum selection clause. That was probably the likeliest dispute to arise, and one they would be particularly desirous of resolving amicably, the goal of the clause. Were Abbott’s interpretation of the clause correct, moreover, we would be at a loss to know how the clause could have been drafted to bring this dispute within its scope. At argument Abbott’s lawyer suggested that “the parties’ relationship” could have been substituted for “this Agreement.” But that would have invited Abbott to argue that the dispute in this case arose not from the parties’ relationship but from Takeda’s unilateral misconduct and Delaware fiduciary law.
Abbott has one good interpretive argument, which is that a “but for” test of “arising out of’ or “related to” would be unsound. For then if Abbott and Takeda had a dispute over an unrelated agreement made 20 years later, Takeda could argue that it arose from the 1985 agreement because if it hadn’t been for what the parties learned about each other in operating under the agreement they would not have included in the later agreement the clause giving rise to the dispute. Takeda’s
*426
lawyer at argument readily conceded that the forum selection clause should not be stretched that far, that is, to its literal limits. “But-for causation is an unsatisfactory understanding of language referring to ‘disputes arising out of an agreement. Let us suppose that while inspecting Om-ron’s facilities, a manager of Maclaren stepped on a baby rattle and fell. Would the ensuing tort litigation go to the High Court of Justice in the United Kingdom just because, but for the distribution agreement, none of Maclaren’s employees would have been on Omron’s premises?”
Omron Healthcare, Inc. v. Maclaren Exports Ltd.,
All that is left for Abbott to argue is that it would be “unreasonable” to force it to litigate its suit in Japan. If so, Illinois law would not require compliance with the forum selection clause.
Yamada Corp. v. Yasuda Fire & Marine Ins. Co., supra,
AFFIRMED.
